Please assess the completion status of the following clinical trial:

Trial Title: FURosemide Stress Test to Predict Need of Renal Replacement THERapy in Ischemic Acute Tubular Necrosis in ICU

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age over 18 years old~* Hospitalized in ICU at day of inclusion~* Diagnosis of sepsis defined as proven or suspected infection and increase of the SOFA (Sequential Organ Failure Assessment) score by 2 points or more compared to basal OR Cardiothoracic surgery with CBP (Cardiopulmonary bypass) within 72 hours before inclusion~* Adequate cardiac output and volemia assessed by cardiac ultrasound, venous saturation in Oxygen (ScVO2) or ΔPP~* Hemodynamic stabilization : stable norepinephrine dosage (or \<20% variations) with no vascular filling during the last 3 hours~* AKI stage I or II in KDIGO classification~Exclusion Criteria:~* Chronic Kidney Disease with glomerular filtration rate ≤ 30 ml/mn/1,73m2~* Obstructive AKI~* AKI stage III in KDIGO classification~* Known allergy to loop diuretics~* Contraindications to Furosemide~* FST not feasible within 12 hours of eligibility~* Previous AKI during the same hospitalization~* Pregnancy or breastfeeding women~* Subject under a legal protective measure~* No affiliation to a social regime or CMU

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FST (Type: EXPERIMENTAL): FUROSEMIDE STRESS TEST

Based on this trial design, predict the completion outcome and termination type (if applicable).